Related Experiment Videos

[Acute bacterial and fungal neonatal meningitis]

P Lequien1, C Gremillet, N Kacet

  • 1Service de médecine néonatale, hôpital calmette, Lille.

Insights

Neonatal meningitis, caused by bacteria like Streptococcus group B, E. coli, or Listeria, presents early with poor prognosis or later as a complication. Treatment requires broad-spectrum antibiotics due to frequent multi-resistance.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Neonatal Medicine

Context:

  • Neonatal meningitis is a severe infection in newborns.
  • It can be transmitted from mother to fetus or arise postnatally.
  • Risk factors include prematurity and pre-existing pathologies.

Purpose:

  • To outline the mechanisms and pathogens of neonatal meningitis.
  • To discuss the impact of onset timing on prognosis.
  • To highlight challenges in treatment due to antimicrobial resistance.

Summary:

  • Neonatal meningitis involves pathogens like Streptococcus group B, Escherichia coli, and Listeria monocytogenes.
  • Early-onset meningitis (prenatal transmission) has a poor prognosis.
  • Postnatal meningitis, often linked to prematurity, involves diverse, frequently multi-resistant bacteria and yeasts.

Impact:

  • Understanding pathogen transmission and resistance is crucial for effective treatment.
  • Advances in biology clarify cerebral complications affecting long-term outcomes.
  • Broad-spectrum antibiotics are essential due to the variety of causative organisms and their resistance patterns.

Related Concept Videos